logo
  

Korn Ferry Board Elects Jerry Leamon To Succeed Christina Gold As Non-Executive Chair

Management consulting firm Korn Ferry (KFY) announced Friday the election of a new member to its Board of Directors, in addition to the appointment of a new Non-Executive Chair.

The company said Christina Gold, who has served on the firm's Board since 2014, and most recently as the Non-Executive Chair since 2019, retires from the Board.

Current Board member Jerry Leamon succeeds Gold as Non-Executive Chair as part of a planned succession.

Meanwhile, Charles Harrington joins as a Board Director and George Shaheen has retired from the Board after more than 12 years of total service, including as Non-Executive Chair from 2012 to 2019.

Harrington brings to Korn Ferry's Board extensive experience in strategy development and execution, transformation, operations, and technology development. Over his nearly 40-year career at Parsons Corporation, Harrington held increasing roles of responsibility, including 13 years as CEO, 12 years as President, and two years as CFO, EVP, and Treasurer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT